Showing results (41-50 of 51) with videos related to
Sort By:
Pageof 6
The Journal of Biological Chemistry|June 17, 2021
A cancer mutation promotes EphA4 oligomerization and signaling by altering the conformation of the SAM domainTaylor P Light, Maricel Gomez-Soler, Zichen Wang, et al.European Journal of Medicinal Chemistry|November 4, 2024
Lipidation and PEGylation strategies to prolong the in vivo half-life of a nanomolar EphA4 receptor antagonistMaricel Gomez-Soler, Erika J Olson, Elena Rubio de la Torre, et al.Life Science Alliance|April 1, 2025
The RBR E3 ubiquitin ligase HOIL-1 can ubiquitinate diverse non-protein substrates in vitroXiangyi S Wang, Jenny Jiou, Anthony Cerra, et al.European Journal of Medicinal Chemistry|March 25, 2024
Lipidation and PEGylation Strategies to Prolong the in Vivo Half-Life of a Nanomolar EphA4 Receptor AntagonistMaricel Gomez-Soler, Erika J Olson, Elena Rubio de la Torre, et al.Nature Communications|June 19, 2023
Structural mapping of PEAK pseudokinase interactions identifies 14-3-3 as a molecular switch for PEAK3 signalingMichael J Roy, Minglyanna G Surudoi, Ashleigh Kropp, et al.Redox Biology|December 6, 2022
Design and characterization of a heterobifunctional degrader of KEAP1Hao Chen, Nghi H Nguyen, Charlene M Magtoto, et al.Nature|April 22, 2026
Ubiquitination of glycogen and metabolites in cells and tissuesMarco Jochem, Simon A Cobbold, Craig A Goodman, et al.Frontiers in Chemistry|May 2, 2022
Insights Into Drug Repurposing, as Well as Specificity and Compound Properties of Piperidine-Based SARS-CoV-2 PLpro InhibitorsDale J Calleja, Nathan Kuchel, Bernadine G C Lu, et al.The EMBO Journal|August 27, 2020
Mechanism and inhibition of the papain-like protease, PLpro, of SARS-CoV-2Theresa Klemm, Gregor Ebert, Dale J Calleja, et al.Nature Communications|April 3, 2025
A novel PLpro inhibitor improves outcomes in a pre-clinical model of long COVIDStefanie M Bader, Dale J Calleja, Shane M Devine, et al.Pageof 6